Reply To: SARS cov2 and Covid 19

Home Forums Discussion Forum SARS cov2 and Covid 19 Reply To: SARS cov2 and Covid 19


And a little more:

“Pulmatrix Inc (NASDAQ:PULM) And Its Partner Sensory Cloud Announce FEND’s Commercial Rollout”

” that FEND’s commercial launch is an important milestone for his company because it will help to combat the coronavirus pandemic more effectively.”

A pandemic their Respiratory and Allergy Expert appointed to their Scientific Advisory Board states isn’t happening….?

” They are optimistic that FEND will not only help to reduce the spread of the coronavirus but that it will help to make a notable impact in fighting against the pandemic at a global scale. Pulmatrix also expects to receive royalties from Sensory Cloud as part of their distribution agreement.”

What’s going on?